Development of in vitro detection techniques for analysing allergen-specific t cell responses in humans

Project Information

SPIEWAK RADOSLAW

Grant agreement ID: QLK4-CT-2002-51504

Project closed

Start date 1 January 2003

End date 31 December 2004

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 140 600,00

EU contribution € 140 600,00

Coordinated by

VRIJE UNIVERSITEIT MEDICAL CENTER
Netherlands

Objective

The project aims at the development of a reliable in vitro T cell test system for diagnosis of contact allergy. Limitations of previous T cell-based models will be overcome through supplementation with recombinant cytokine cocktails and addition of monocot-derived antigen presenting cells.

Fields of science

• medical and health sciences › clinical medicine › allergology

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-4. - Key action Environment and Health

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

VRIJE UNIVERSITEIT MEDICAL CENTER

• EU contribution: No data
• Address: De Boelelaan 1117 ; 1007 MB AMSTERDAM ; Netherlands
• Total cost: No data